Endometrial cancer patients see new hope as FDA approves 'transforming' immunotherapy drug

The FDA has approved a new drug for some adult patients with endometrial cancer. Jemperli (dostarlimably) — made by U.K. company GSK — is intended for primary advanced or recurrent disease.


http://dlvr.it/TBfvHW